EXHIBIT 10.42
AMENDMENT
This Amendment to Funding Agreement is entered into as of the 30th day
of December, 2003, by and between Xxxx Xxxxxxxx ("Investor") and DNAPRINT
genomics, Inc. (the "Company").
W I T N E S S E T H:
WHEREAS, the parties hereto are parties to a Funding Agreement dated on
or about October 25, 2002, (the "Agreement"), pursuant to which the Investor has
advanced certain funds to the Company; and
WHEREAS, the parties desire to memorialize the modifications in this
Amendment.
NOW, THEREFORE, in consideration of the premises and the mutual
covenants contained herein, the parties agree as follows:
1. Capitalized terms used herein but not defined herein
shall have the same meaning given to those in the
Agreement.
2. The term of the Agreement and the Consideration
associated therewith are hereby amended to extend
such dates for repayment of any and all funds
advanced pursuant to the Agreement, whether or not
such advances are represented by independent
promissory notes, until December 31, 2004, and the
Investor shall take no action to collect any such
funds unless and until such funds shall not have been
repaid by December 31, 2004.
3. Except as explicitly modified herein, the Agreement
shall remain in full force and effect.
IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first above written.
DNAPrint genomics, Inc.
By: /s/ Xxxx Xxxxxxxx
____________________________________
/s/ Xxxx Xxxxxxxx
_______________________________________
Xxxx Xxxxxxxx